{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:44:55Z","timestamp":1793839495854,"version":"4.6.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.clinthera.2022.07.005","type":"journal-article","created":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T16:43:18Z","timestamp":1659372198000},"page":"1203-1213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effect of Dronedarone in the Treatment of Atrial Fibrillation in the Asian Population: Post Hoc Analysis of the ATHENA Trial"],"prefix":"10.1016","volume":"44","author":[{"given":"Changsheng","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiunn-Lee","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gi-Byoung","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattias","family":"Wieloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2022.07.005_bib0001","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/1747493019897870","article-title":"Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge","volume":"16","author":"Lippi","year":"2021","journal-title":"Int J Stroke"},{"key":"10.1016\/j.clinthera.2022.07.005_bib0002","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1136\/heartjnl-2018-314267","article-title":"Mechanisms of atrial fibrillation","volume":"105","author":"Wijesurendra","year":"2019","journal-title":"Heart"},{"key":"10.1016\/j.clinthera.2022.07.005_bib0003","volume":"2017","year":"2017"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2022.07.005_bib0004","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euv231","article-title":"Asian strategy for stroke prevention in atrial fibrillation","volume":"17","author":"Chiang","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.clinthera.2022.07.005_bib0005","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1136\/heartjnl-2018-314471","article-title":"Increasing trends in hospitalisations due to atrial fibrillation in Australia from 1993 to 2013","volume":"105","author":"Gallagher","year":"2019","journal-title":"Heart"},{"key":"10.1016\/j.clinthera.2022.07.005_bib0006","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.vhri.2013.02.008","article-title":"Economic burden of individual suffering from atrial fibrillation\u2013related stroke in China","volume":"2","author":"Hu","year":"2013","journal-title":"Value Health Region Issues"},{"key":"10.1016\/j.clinthera.2022.07.005_bib0007","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.4070\/kcj.2018.0339","article-title":"2018 Korean guideline of atrial fibrillation management","volume":"48","author":"Joung","year":"2018","journal-title":"Korean Circ J"},{"key":"10.1016\/j.clinthera.2022.07.005_bib0008","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.ijcard.2012.12.093","article-title":"Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century","volume":"167","author":"Ball","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.clinthera.2022.07.005_bib0009","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4070\/kcj.2016.0045","article-title":"The trends of atrial fibrillation-related hospital visit and cost, treatment pattern and mortality in Korea: 10-year nationwide sample cohort data","volume":"47","author":"Lee","year":"2017","journal-title":"Korean Circ J"},{"key":"10.1016\/j.clinthera.2022.07.005_bib0010","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.hlc.2017.05.120","article-title":"Epidemiology of atrial fibrillation: the Australian and Asia-Pacific perspective","volume":"26","author":"Wong","year":"2017","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.clinthera.2022.07.005_bib0011","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2022.07.005_bib0012","doi-asserted-by":"crossref","first-page":"16102","DOI":"10.1038\/s41598-020-73115-y","article-title":"Comparative clinical outcomes of dronedarone and sotalol in Asian patients with atrial fibrillation: a nationwide cohort study","volume":"10","author":"Lee","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.clinthera.2022.07.005_bib0013","doi-asserted-by":"crossref","first-page":"4856","DOI":"10.12659\/MSM.916855","article-title":"The association between the use of antiarrhythmic drugs in non-valvular atrial fibrillation and patient prognosis using data from the China Atrial Fibrillation (China-AF) Registry","volume":"25","author":"Hou","year":"2019","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.clinthera.2022.07.005_bib0014","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1540-8167.2010.01764.x","article-title":"A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study","volume":"21","author":"Le Heuzey","year":"2010","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.clinthera.2022.07.005_bib0015","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/pds.5233","article-title":"Risk of interstitial lung disease in patients treated for atrial fibrillation with dronedarone versus other antiarrhythmics","volume":"30","author":"Tave","year":"2021","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.clinthera.2022.07.005_bib0016","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJMoa0803778","article-title":"Effect of dronedarone on cardiovascular events in atrial fibrillation","volume":"360","author":"Hohnloser","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2022.07.005_bib0017","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa054686","article-title":"Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter","volume":"357","author":"Singh","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2022.07.005_bib0018","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.clinthera.2014.07.013","article-title":"Efficacy of dronedarone versus propafenone in the maintenance of sinus rhythm in patients with atrial fibrillation after electrical cardioversion","volume":"36","author":"Chun","year":"2014","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2022.07.005_bib0019","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1540-8167.2007.01016.x","volume":"19","author":"Hohnloser","year":"2008","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.clinthera.2022.07.005_bib0020","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2022.07.005_bib0021","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/clc.23463","article-title":"Efficacy and safety of dronedarone by atrial fibrillation history duration: Insights from the ATHENA study","volume":"43","author":"Blomstr\u00f6m-Lundqvist","year":"2020","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.clinthera.2022.07.005_bib0022","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.amjcard.2010.11.028","article-title":"Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial)","volume":"107","author":"Page","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2022.07.005_bib0023","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.amjcard.2020.08.026","article-title":"Outcomes associated with dronedarone use in patients with atrial fibrillation","volume":"135","author":"Goehring","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2022.07.005_bib0024","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and stroke statistics-2021 update: a report from the American Heart Association","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2022.07.005_bib0025","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1160\/TH13-11-0948","article-title":"Stroke prevention in atrial fibrillation: an Asian perspective","volume":"112","author":"Chiang","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.clinthera.2022.07.005_bib0026","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12872-018-0746-z","article-title":"Better clinical outcome with direct oral anticoagulants in hospitalized heart failure patients with atrial fibrillation","volume":"18","author":"Yoshihisa","year":"2018","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.clinthera.2022.07.005_bib0027","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jchf.2016.07.012","article-title":"Efficacy and safety of novel oral anticoagulants in patients with atrial fibrillation and heart failure: a meta-analysis","volume":"4","author":"Savarese","year":"2016","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.clinthera.2022.07.005_bib0028","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jacc.2007.01.098","article-title":"Racial\/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation","volume":"50","author":"Shen","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2022.07.005_bib0029","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1161\/STROKEAHA.113.000990","article-title":"Dabigatran versus warfarin: effects on ischemic and hemorrhagic strokes and bleeding in Asians and non-Asians with atrial fibrillation","volume":"44","author":"Hori","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.clinthera.2022.07.005_bib0030","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1161\/STROKEAHA.113.002968","article-title":"Rivaroxaban for stroke prevention in East Asian patients from the ROCKET AF trial","volume":"45","author":"Wong","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.clinthera.2022.07.005_bib0031","article-title":"Edoxaban vs. warfarin in East Asian patients with atrial fibrillation\u2013an ENGAGE AF-TIMI 48 subanalysis","author":"Yamashita","year":"2016","journal-title":"Circ J"},{"key":"10.1016\/j.clinthera.2022.07.005_bib0032","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ahj.2014.06.005","article-title":"Efficacy and safety of apixaban compared with warfarin for stroke prevention in patients with atrial fibrillation from East Asia: a subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial","volume":"168","author":"Goto","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.clinthera.2022.07.005_bib0033","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2217\/fca.09.49","article-title":"Atrial fibrillation and ethnicity: the known, the unknown and the paradox","volume":"5","author":"Soliman","year":"2009","journal-title":"Future Cardiol"},{"key":"10.1016\/j.clinthera.2022.07.005_bib0034","unstructured":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/022425lbl.pdf. Accessed May 23, 2022."},{"key":"10.1016\/j.clinthera.2022.07.005_bib0035","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/00498250400021796","article-title":"Ethnic differences between Japanese and Caucasians in the expression levels of mRNAs for CYP3A4, CYP3A5 and CYP3A7: lack of co-regulation of the expression of CYP3A in Japanese livers","volume":"35","author":"Yamaori","year":"2005","journal-title":"Xenobiotica"},{"key":"10.1016\/j.clinthera.2022.07.005_bib0036","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1177\/0091270004268128","article-title":"Differences in drug pharmacokinetics between East Asians and Caucasians and the role of genetic polymorphisms","volume":"44","author":"Kim","year":"2004","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2022.07.005_bib0037","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/bcp.12884","article-title":"Absence of ethnic differences in the pharmacokinetics of moxifloxacin, simvastatin, and meloxicam among three East Asian populations and Caucasians","volume":"81","author":"Hasunuma","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2022.07.005_bib0038","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1254\/jphs.FP0061311","article-title":"Effects of continuous ingestion of herbal teas on intestinal CYP3A in the rat","volume":"103","author":"Matsuda","year":"2007","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.clinthera.2022.07.005_bib0039","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2022.07.005_bib0040","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/ejhf.2487","article-title":"Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction: post-hoc analysis of the ATHENA trial","volume":"24","author":"Vaduganathan","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.clinthera.2022.07.005_bib0041","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/CIRCULATIONAHA.121.056323","article-title":"Early rhythm control therapy in patients with atrial fibrillation and heart failure","volume":"144","author":"Rillig","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2022.07.005_bib0042","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/eurheartj\/ehab593","article-title":"Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial","volume":"43","author":"Willems","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2022.07.005_bib0043","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/cts.12771","article-title":"Pharmacogenomics in Asian subpopulations and impacts on commonly prescribed medications","volume":"13","author":"Lo","year":"2020","journal-title":"Clin Trans Sci"},{"key":"10.1016\/j.clinthera.2022.07.005_bib0044","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1136\/bmj.38803.528113.55","article-title":"Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine","volume":"332","author":"McDowell","year":"2006","journal-title":"BMJ"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291822002363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291822002363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:57:12Z","timestamp":1758963432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291822002363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0149291822002363"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2022.07.005","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Dronedarone in the Treatment of Atrial Fibrillation in the Asian Population: Post Hoc Analysis of the ATHENA Trial","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2022.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}